Teladoc Historical Balance Sheet

TDOC Stock

USD 8.41 0.24 2.94%

Trend analysis of Teladoc balance sheet accounts such as Total Stockholder Equity of 1.4 B, Other Liab of 38.6 M, Property Plant And Equipment Net of 38.5 M or Net Debt of 235.4 M provides information on Teladoc's total assets, liabilities, and equity, which is the actual value of Teladoc to its prevalent stockholders. By breaking down trends over time using Teladoc balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Teladoc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Teladoc is a good buy for the upcoming year.

Teladoc Inventory

30.99 Million

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Teladoc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

For information on how to trade Teladoc Stock refer to our How to Trade Teladoc Stock guide.

About Teladoc Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Teladoc at a specified time, usually calculated after every quarter, six months, or one year. Teladoc Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Teladoc and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Teladoc currently owns. An asset can also be divided into two categories, current and non-current.

Teladoc Balance Sheet Chart

At present, Teladoc's Other Current Liabilities is projected to increase significantly based on the last few years of reporting. The current year's Total Current Liabilities is expected to grow to about 988.6 M, whereas Short and Long Term Debt Total is forecasted to decline to about 797.6 M.

Short Long Term Debt Total Other Current Liab Total Current Liabilities Other Liab Accumulated Other Comprehensive Income

Add Fundamental

Total Current Liabilities

Total Current Liabilities is an item on Teladoc balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Teladoc are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Accumulated Other Comprehensive Income

Gains and losses not included in net income that are recorded in shareholders' equity, reflecting changes in the value of assets or liabilities that are not realized.

Most accounts from Teladoc's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Teladoc current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Teladoc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

For information on how to trade Teladoc Stock refer to our How to Trade Teladoc Stock guide.At present, Teladoc's Other Current Liabilities is projected to increase significantly based on the last few years of reporting. The current year's Total Current Liabilities is expected to grow to about 988.6 M, whereas Short and Long Term Debt Total is forecasted to decline to about 797.6 M.

	2022	2023	2024	2025 (projected)
Short and Long Term Debt Total	1.6B	1.6B	1.6B	797.6M
Total Assets	4.3B	4.4B	3.5B	4.8B

Short Long Term Debt Total Total Assets

Teladoc balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets
Total Assets		0.68	0.25	0.37	0.99	0.87	0.78	0.74	-0.12	0.79	0.53	0.99	0.26	0.21	0.71	0.54	0.59	0.97	-0.34	0.56	0.69	0.63	0.7	0.68	0.5	0.57
Short Long Term Debt Total	0.68		0.64	0.73	0.57	0.91	0.97	0.89	-0.74	0.97	0.89	0.6	0.77	0.75	0.98	0.89	0.94	0.5	-0.49	0.95	1.0	0.95	0.94	1.0	0.87	0.91
Other Current Liab	0.25	0.64		0.99	0.1	0.49	0.55	0.45	-0.86	0.54	0.87	0.12	0.91	0.89	0.54	0.87	0.82	0.02	-0.32	0.66	0.63	0.77	0.78	0.64	0.87	0.86
Total Current Liabilities	0.37	0.73	0.99		0.22	0.59	0.65	0.54	-0.86	0.64	0.92	0.25	0.93	0.9	0.64	0.92	0.89	0.14	-0.37	0.74	0.72	0.84	0.85	0.73	0.92	0.91
Total Stockholder Equity	0.99	0.57	0.1	0.22		0.81	0.69	0.67	0.04	0.7	0.39	1.0	0.1	0.05	0.62	0.4	0.45	1.0	-0.28	0.45	0.59	0.5	0.58	0.58	0.36	0.42
Other Liab	0.87	0.91	0.49	0.59	0.81		0.93	0.85	-0.44	0.92	0.78	0.83	0.53	0.48	0.9	0.79	0.81	0.76	-0.54	0.8	0.91	0.82	0.85	0.91	0.73	0.8
Property Plant And Equipment Net	0.78	0.97	0.55	0.65	0.69	0.93		0.89	-0.63	0.98	0.85	0.71	0.68	0.67	0.98	0.85	0.9	0.62	-0.51	0.91	0.97	0.92	0.92	0.97	0.83	0.87
Net Debt	0.74	0.89	0.45	0.54	0.67	0.85	0.89		-0.57	0.93	0.68	0.7	0.58	0.55	0.92	0.69	0.81	0.61	-0.37	0.76	0.9	0.88	0.86	0.89	0.69	0.73
Retained Earnings	-0.12	-0.74	-0.86	-0.86	0.04	-0.44	-0.63	-0.57		-0.64	-0.85	0.0	-0.97	-0.98	-0.68	-0.85	-0.87	0.13	0.32	-0.78	-0.73	-0.84	-0.79	-0.74	-0.87	-0.85
Accounts Payable	0.79	0.97	0.54	0.64	0.7	0.92	0.98	0.93	-0.64		0.83	0.73	0.68	0.67	0.99	0.83	0.9	0.64	-0.47	0.91	0.98	0.94	0.94	0.97	0.81	0.86
Cash	0.53	0.89	0.87	0.92	0.39	0.78	0.85	0.68	-0.85	0.83		0.41	0.92	0.9	0.85	1.0	0.98	0.3	-0.5	0.89	0.89	0.93	0.94	0.89	0.97	1.0
Non Current Assets Total	0.99	0.6	0.12	0.25	1.0	0.83	0.71	0.7	0.0	0.73	0.41		0.13	0.08	0.65	0.43	0.48	0.99	-0.29	0.48	0.62	0.53	0.61	0.61	0.39	0.45
Non Currrent Assets Other	0.26	0.77	0.91	0.93	0.1	0.53	0.68	0.58	-0.97	0.68	0.92	0.13		0.97	0.71	0.91	0.91	0.01	-0.35	0.8	0.76	0.86	0.85	0.77	0.96	0.91
Other Assets	0.21	0.75	0.89	0.9	0.05	0.48	0.67	0.55	-0.98	0.67	0.9	0.08	0.97		0.7	0.89	0.89	-0.04	-0.35	0.83	0.74	0.86	0.83	0.75	0.9	0.9
Long Term Debt	0.71	0.98	0.54	0.64	0.62	0.9	0.98	0.92	-0.68	0.99	0.85	0.65	0.71	0.7		0.85	0.91	0.55	-0.49	0.92	0.98	0.93	0.92	0.98	0.82	0.88
Cash And Short Term Investments	0.54	0.89	0.87	0.92	0.4	0.79	0.85	0.69	-0.85	0.83	1.0	0.43	0.91	0.89	0.85		0.98	0.32	-0.53	0.89	0.89	0.93	0.94	0.89	0.97	1.0
Net Receivables	0.59	0.94	0.82	0.89	0.45	0.81	0.9	0.81	-0.87	0.9	0.98	0.48	0.91	0.89	0.91	0.98		0.37	-0.48	0.92	0.94	0.98	0.98	0.94	0.97	0.99
Good Will	0.97	0.5	0.02	0.14	1.0	0.76	0.62	0.61	0.13	0.64	0.3	0.99	0.01	-0.04	0.55	0.32	0.37		-0.25	0.37	0.52	0.41	0.5	0.51	0.28	0.34
Common Stock Total Equity	-0.34	-0.49	-0.32	-0.37	-0.28	-0.54	-0.51	-0.37	0.32	-0.47	-0.5	-0.29	-0.35	-0.35	-0.49	-0.53	-0.48	-0.25		-0.49	-0.5	-0.44	-0.43	-0.49	-0.45	-0.51
Common Stock Shares Outstanding	0.56	0.95	0.66	0.74	0.45	0.8	0.91	0.76	-0.78	0.91	0.89	0.48	0.8	0.83	0.92	0.89	0.92	0.37	-0.49		0.95	0.91	0.9	0.95	0.86	0.91
Non Current Liabilities Total	0.69	1.0	0.63	0.72	0.59	0.91	0.97	0.9	-0.73	0.98	0.89	0.62	0.76	0.74	0.98	0.89	0.94	0.52	-0.5	0.95		0.95	0.94	1.0	0.86	0.91
Other Current Assets	0.63	0.95	0.77	0.84	0.5	0.82	0.92	0.88	-0.84	0.94	0.93	0.53	0.86	0.86	0.93	0.93	0.98	0.41	-0.44	0.91	0.95		0.99	0.95	0.92	0.95
Other Stockholder Equity	0.7	0.94	0.78	0.85	0.58	0.85	0.92	0.86	-0.79	0.94	0.94	0.61	0.85	0.83	0.92	0.94	0.98	0.5	-0.43	0.9	0.94	0.99		0.94	0.94	0.96
Total Liab	0.68	1.0	0.64	0.73	0.58	0.91	0.97	0.89	-0.74	0.97	0.89	0.61	0.77	0.75	0.98	0.89	0.94	0.51	-0.49	0.95	1.0	0.95	0.94		0.87	0.91
Property Plant And Equipment Gross	0.5	0.87	0.87	0.92	0.36	0.73	0.83	0.69	-0.87	0.81	0.97	0.39	0.96	0.9	0.82	0.97	0.97	0.28	-0.45	0.86	0.86	0.92	0.94	0.87		0.97
Total Current Assets	0.57	0.91	0.86	0.91	0.42	0.8	0.87	0.73	-0.85	0.86	1.0	0.45	0.91	0.9	0.88	1.0	0.99	0.34	-0.51	0.91	0.91	0.95	0.96	0.91	0.97

Click cells to compare fundamentals

Teladoc Account Relationship Matchups

Teladoc balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	17.8B	17.7B	4.3B	4.4B	3.5B	4.8B
Short Long Term Debt Total	1.5B	1.3B	1.6B	1.6B	1.6B	797.6M
Other Current Liab	178.6M	169.1M	324.5M	257.0M	801.0M	841.0M
Total Current Liabilities	332.6M	331.0M	399.8M	420.6M	941.5M	988.6M
Total Stockholder Equity	15.9B	16.0B	2.3B	2.3B	1.5B	1.4B
Other Liab	33.2M	106.2M	81.1M	56.4M	64.9M	38.6M
Property Plant And Equipment Net	75.2M	74.0M	71.5M	72.1M	56.6M	38.5M
Net Debt	732.0M	374.0M	655.1M	468.6M	286.3M	235.4M
Retained Earnings	(992.7M)	(1.4B)	(15.0B)	(15.2B)	(16.2B)	(15.4B)
Accounts Payable	46.0M	47.3M	47.7M	43.6M	33.1M	22.5M
Cash	733.3M	893.5M	918.2M	1.1B	1.3B	1.4B
Non Current Assets Total	16.7B	16.5B	3.0B	2.9B	1.9B	1.8B
Non Currrent Assets Other	18.4M	20.7M	48.5M	80.3M	81.5M	85.6M
Other Assets	6.5M	2.1K	20.7M	48.5M	55.8M	58.6M
Long Term Debt	1.4B	1.2B	1.5B	1.5B	991.4M	717.7M
Cash And Short Term Investments	786.6M	896.0M	918.2M	1.1B	1.3B	1.4B
Net Receivables	169.3M	169.0M	210.6M	230.1M	224.0M	235.2M
Good Will	746.1M	14.6B	14.5B	1.1B	283.2M	269.0M
Common Stock Total Equity	73K	150K	160K	163K	146.7K	291.3K
Common Stock Shares Outstanding	90.5M	156.9M	161.5M	164.6M	170.6M	96.7M
Liabilities And Stockholders Equity	17.8B	17.7B	4.3B	4.4B	3.5B	4.8B
Non Current Liabilities Total	1.5B	1.4B	1.6B	1.6B	1.6B	829.2M
Other Current Assets	94.5M	87.4M	130.3M	105.8M	103.5M	108.7M
Other Stockholder Equity	16.9B	17.5B	17.4B	17.6B	17.8B	18.6B
Total Liab	1.9B	1.7B	2.0B	2.1B	2.0B	1.0B
Property Plant And Equipment Gross	75.2M	74.0M	71.5M	131.8M	127.9M	134.3M
Total Current Assets	1.1B	1.2B	1.3B	1.5B	1.7B	1.7B
Accumulated Other Comprehensive Income	18.5M	(6.3M)	(42.8M)	(37.0M)	(38.4M)	(36.5M)
Intangible Assets	2.0B	1.9B	1.8B	1.7B	1.4B	876.6M
Common Stock	150K	160K	163K	167K	173K	265.4K
Property Plant Equipment	10.3M	28.6M	74.0M	29.6M	34.1M	19.4M
Net Tangible Assets	67.5M	(665.2M)	(368.7M)	(556.1M)	(500.5M)	(475.5M)
Current Deferred Revenue	52.4M	75.6M	90.5M	95.7M	79.3M	42.5M
Deferred Long Term Liab	21.7M	104.6M	2.4M	54.8M	63.0M	66.2M
Short Term Debt	54.0M	26M	13.6M	10.8M	12.4M	15.8M
Retained Earnings Total Equity	(507.5M)	(992.7M)	(1.4B)	(15.0B)	(13.5B)	(12.8B)
Long Term Debt Total	440.4M	1.4B	1.2B	1.5B	1.8B	1.9B
Capital Surpluse	1.5B	16.9B	17.5B	17.4B	20.0B	21.0B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
S	SentinelOne
GM	General Motors

When determining whether Teladoc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Teladoc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Teladoc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Teladoc Stock:

How To Invest In Teladoc

Details

Is Teladoc Stock a good investment?

Details

What is Teladoc's Net Worth?

Details

Largest Health Care Technology Companies

View

Largest Health Care Equipment & Services Companies

View

For information on how to trade Teladoc Stock refer to our How to Trade Teladoc Stock guide.

You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Teladoc. If investors know Teladoc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Teladoc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(5.87)

Revenue Per Share

15.065

Quarterly Revenue Growth

(0.03)

Return On Assets

(0.03)

Return On Equity

(0.52)

The market value of Teladoc is measured differently than its book value, which is the value of Teladoc that is recorded on the company's balance sheet. Investors also form their own opinion of Teladoc's value that differs from its market value or its book value, called intrinsic value, which is Teladoc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Teladoc's market value can be influenced by many factors that don't directly affect Teladoc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Teladoc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Teladoc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Teladoc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Teladoc Historical Balance Sheet

Teladoc Inventory

30.99 Million

About Teladoc Balance Sheet Analysis

Teladoc Balance Sheet Chart

Total Current Liabilities

Accumulated Other Comprehensive Income

Teladoc balance sheet Correlations

Teladoc Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Teladoc balance sheet Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Liabilities Total	+ 1.0	Short Long Term Debt Total
Total Liab	+ 1.0	Short Long Term Debt Total
Non Current Assets Total	+ 1.0	Total Stockholder Equity
Good Will	+ 1.0	Total Stockholder Equity
Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash

Other Assets	- 0.98	Retained Earnings
Non Currrent Assets Other	- 0.97	Retained Earnings
Property Plant And Equipment Gross	- 0.87	Retained Earnings
Net Receivables	- 0.87	Retained Earnings
Retained Earnings	- 0.86	Total Current Liabilities
Retained Earnings	- 0.86	Other Current Liab